Physician profile
Patrick A Huck
NPI 1053678466
$3,860.11
in general payments reported to CMS, 2019-2025
16 companies · $664 in 2025
The $664 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $808 · 2022: $955 · 2023: $934 · 2024: $500 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,097.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,097.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,024.35 | 2021-2025 | Eterna, Proclaim, Nt2000ix |
| Merz Pharmaceuticals, LLC | $218.87 | 2021-2025 | Xeomin |
| Si-Bone, INC. | $189.65 | 2021-2025 | |
| Lundbeck LLC | $139.84 | 2022-2024 | Vyepti |
| Grt US Holding, INC. | $60.12 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $55.96 | 2022 | |
| Vertos Medical, INC. | $24.05 | 2022 | |
| Stryker Corporation | $21.49 | 2021 | |
| Relievant Medsystems, INC. | $19.32 | 2023 | Intracept |
| Vertex Pharmaceuticals Incorporated | $18.49 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $16.64 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $15.52 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.86 | 2022 | |
| Lilly USA, LLC | $14.59 | 2021 | |
| Collegium Pharmaceutical, INC. | $14.45 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11.91 | 2023-2024 | Da Vinci Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Huck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.